Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Recruiting · NCT05947669 · Registry updated 2023-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, intestinal disorder | Recruiting | Phase 3 | 2023-08-24 | NCT05947669 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aalborg University Hospital | 135 |
| Odense University Hospital | 253 |
| Royal Marsden NHS Foundation Trust | 89 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Oncology Odense University Hospital | Odense | Denmark | 1 |
| Department of Oncology, Aalborg University Hospital | Aalborg | Denmark | 2 |
| the Royal Marsden Hospital | London | United Kingdom | 5 |